Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)

This study has been terminated.
(End of recruitment period)
Sponsor:
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00224575
First received: September 13, 2005
Last updated: September 29, 2009
Last verified: April 2008

September 13, 2005
September 29, 2009
November 2004
November 2005   (final data collection date for primary outcome measure)
therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly [ Time Frame: during hospitalization ] [ Designated as safety issue: No ]
to evaluate the therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly
Complete list of historical versions of study NCT00224575 on ClinicalTrials.gov Archive Site
part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months [ Time Frame: during hospitalization ] [ Designated as safety issue: Yes ]
to determine in the treatment modification the part link with diagnosis reassessment and the part link with treatment optimization
Not Provided
Not Provided
 
Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly
Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

not desired

Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Myocardial Ischemia
  • Other: diagnosis reassessment
    Strategy of diagnosis reassessment following a decision tree.
    Other Name: no other names to specified
  • Other: Diagnosis strategy and subsequent therapeutic reassessment
    Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy
Experimental: 1
All patients are in that arms. They all receive the diagnosis reassessment strategy.
Interventions:
  • Other: diagnosis reassessment
  • Other: Diagnosis strategy and subsequent therapeutic reassessment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
260
November 2006
November 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion Criteria:

  • acute myocardial infarction
Both
75 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00224575
AOM03099
No
Zakia IDIR, Department Clinical Rechearch of Developpement
Assistance Publique - Hôpitaux de Paris
Not Provided
Principal Investigator: legrain sylvie APHP
Assistance Publique - Hôpitaux de Paris
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP